These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 24550071

  • 1. TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.
    Zhang C, Sturgis EM, Zheng H, Zafereo ME, Wei Q, Li G.
    Int J Cancer; 2014 Oct 01; 135(7):1615-24. PubMed ID: 24550071
    [Abstract] [Full Text] [Related]

  • 2. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.
    Zhang C, Sturgis EM, Zheng H, Song X, Wei P, Jin L, Chao L, Wei Q, Li G.
    Int J Cancer; 2014 Apr 15; 134(8):1907-15. PubMed ID: 24122460
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetic variations associated with telomere length predict the risk of recurrence of non-oropharyngeal head and neck squamous cell carcinoma.
    Sun P, Gu KJ, Zheng G, Sikora AG, Li C, Zafereo M, Wei P, Wu J, Shete S, Liu J, Li G.
    Mol Carcinog; 2024 Sep 15; 63(9):1722-1737. PubMed ID: 38837510
    [Abstract] [Full Text] [Related]

  • 6. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.
    Zhang Y, Sturgis EM, Li Y, Wei Q, Huang Z, Li G.
    Sci Rep; 2017 Jan 03; 7():39765. PubMed ID: 28045062
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
    Zhu L, Sturgis EM, Zhang H, Lu Z, Tao Y, Wei Q, Li G.
    Int J Cancer; 2017 Oct 01; 141(7):1355-1364. PubMed ID: 28646528
    [Abstract] [Full Text] [Related]

  • 9. Association of -308 TNF-α promoter polymorphism with clinical aggressiveness in patients with head and neck squamous cell carcinoma.
    Corrêa GT, Bandeira GA, Cavalcanti BG, de Carvalho Fraga CA, dos Santos EP, Silva TF, Gomez RS, Guimarães AL, De Paula AM.
    Oral Oncol; 2011 Sep 01; 47(9):888-94. PubMed ID: 21788151
    [Abstract] [Full Text] [Related]

  • 10. Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy.
    Chen X, Sturgis EM, Wang C, Cao X, Li Y, Wei Q, Li G.
    Oncotarget; 2016 Jun 07; 7(23):35015-25. PubMed ID: 27145460
    [Abstract] [Full Text] [Related]

  • 11. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.
    Jin L, Sturgis EM, Zhang Y, Huang Z, Wei P, Guo W, Wang Z, Wei Q, Song X, Li G.
    Carcinogenesis; 2013 Jul 07; 34(7):1551-7. PubMed ID: 23508638
    [Abstract] [Full Text] [Related]

  • 12. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck.
    Li F, Sturgis EM, Zafereo ME, Liu Z, Wang LE, Wei Q, Li G.
    Int J Cancer; 2009 Dec 01; 125(11):2660-5. PubMed ID: 19585505
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
    Wang C, Sturgis EM, Chen X, Wei Q, Li G.
    Oncotarget; 2016 Jun 07; 7(23):34472-9. PubMed ID: 27121322
    [Abstract] [Full Text] [Related]

  • 15. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck.
    Wang Z, Sturgis EM, Zhang F, Lei D, Liu Z, Xu L, Song X, Wei Q, Li G.
    Mol Cancer; 2012 Mar 26; 11():17. PubMed ID: 22449259
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
    Uzunoglu FG, Kaufmann C, Wikman H, Güngör C, Bohn BA, Nentwich MF, Reeh M, Pantel K, Bockhorn M, Kutup A, Mann O, Izbicki JR, Vashist YK.
    Ann Surg Oncol; 2012 Jul 26; 19(7):2159-68. PubMed ID: 22395975
    [Abstract] [Full Text] [Related]

  • 17. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
    Zhang F, Sturgis EM, Sun Y, Zhang Y, Wei Q, Zhang C, Zheng H, Li G.
    Int J Cancer; 2015 Nov 15; 137(10):2454-61. PubMed ID: 25976983
    [Abstract] [Full Text] [Related]

  • 18. Association of TNF-α (-238 and -308) promoter polymorphisms with susceptibility of oral squamous cell carcinoma in North Indian population.
    Singh PK, Bogra J, Chandra G, Ahmad MK, Gupta R, Kumar V, Jain A, Ali Mahdi A.
    Cancer Biomark; 2015 Nov 15; 15(2):125-31. PubMed ID: 25519014
    [Abstract] [Full Text] [Related]

  • 19. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
    Ryk C, Koskela LR, Thiel T, Wiklund NP, Steineck G, Schumacher MC, de Verdier PJ.
    Redox Biol; 2015 Dec 15; 6():272-277. PubMed ID: 26298202
    [Abstract] [Full Text] [Related]

  • 20. Influential factors on tumor recurrence in head and neck cancer patients.
    Matthias C, Harréus U, Strange R.
    Eur Arch Otorhinolaryngol; 2006 Jan 15; 263(1):37-42. PubMed ID: 16003553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.